Biomaterial Database

Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. 1985

P Periti, and P Nicoletti, and A Novelli

The study reports the results of an in vitro comparative evaluation of flurithromycin by means of MS-2 research system analyzing the growth curve patterns of recently isolated strains of S. aureus, S. epidermidis, S. faecalis and H. influenzae. Flurithromycin is provided with superior activity to that of josamycin and practically superimposed on that of erythromycin. Of the 4 bacterial species studied, S. faecalis is the most sensitive, followed by Staphylococci and H. influenzae in decreasing order of sensitivity.

UI	MeSH Term	Description	Entries
D007933	Leucomycins	An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004917	Erythromycin	A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.	Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006193	Haemophilus influenzae	A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.	Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D013211	Staphylococcus aureus	Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013212	Staphylococcus epidermidis	A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.
D013293	Enterococcus faecalis	A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.	Streptococcus Group D,Streptococcus faecalis
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor

Related Publications

P Periti, and P Nicoletti, and A Novelli

Clinical evaluation of the Abbott MS-2 antimicrobial susceptibility testing system.

July 1981, American journal of clinical pathology,

P Periti, and P Nicoletti, and A Novelli

Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.

February 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

P Periti, and P Nicoletti, and A Novelli

Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study.

September 1980, Journal of clinical microbiology,

P Periti, and P Nicoletti, and A Novelli

In-vitro antimycoplasmal activity of flurithromycin.

January 1995, The Journal of antimicrobial chemotherapy,

P Periti, and P Nicoletti, and A Novelli

[Critical evaluation of the Abbott MS-2 automatic system in the rapid determination of antibiograms].

March 1985, Quaderni Sclavo di diagnostica clinica e di laboratorio,

P Periti, and P Nicoletti, and A Novelli

Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system.

May 1984, Bollettino dell'Istituto sieroterapico milanese,